These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22943266)

  • 1. Acclimatizing with acetazolamide.
    Basnyat B
    J Travel Med; 2012; 19(5):281-3. PubMed ID: 22943266
    [No Abstract]   [Full Text] [Related]  

  • 2. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness.
    Leshem E; Caine Y; Rosenberg E; Maaravi Y; Hermesh H; Schwartz E
    J Travel Med; 2012; 19(5):308-10. PubMed ID: 22943271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Your patient wants to go to the mountains. You protect him from mountain sickness and altitude edema].
    MMW Fortschr Med; 2005 Apr; 147(14):4-5. PubMed ID: 15887670
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological prevention of acute mountain sickness. Many climbers and trekkers find acetazolamide 500 mg/day to be useful.
    Hackett P
    BMJ; 2001 Jan; 322(7277):48; author reply 49. PubMed ID: 11141167
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide.
    Bärtsch P; Schneider M
    BMJ; 2001 Jan; 322(7277):48-9. PubMed ID: 11141168
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetazolamide or not, prior to ascent?
    DeLellis SM
    J Spec Oper Med; 2010; 10(4):38-40. PubMed ID: 21442590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age is no barrier to success at very high altitudes.
    Stokes S; Kalson NS; Earl M; Whitehead AG; Tyrrell-Marsh I; Frost H; Davies A
    Age Ageing; 2010 Mar; 39(2):262-5. PubMed ID: 20068217
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetazolamide for the prophylaxis of acute mountain sickness.
    Imray C
    BMJ; 2012 Oct; 345():e7077. PubMed ID: 23114063
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetazolamide Use in an Ultra-Runner: A Complicated Treatment Consideration for AMS.
    Biondich AS; Joslin JD
    Wilderness Environ Med; 2016 Mar; 27(1):179-80. PubMed ID: 26520404
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
    Ritchie ND; Baggott AV; Andrew Todd WT
    J Travel Med; 2012; 19(5):298-307. PubMed ID: 22943270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness.
    Dumont L; Tramer MR; Lysakowski C; Mardirosoff C; Kayser B
    High Alt Med Biol; 2003; 4(3):399; author reply 400. PubMed ID: 14561245
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetazolamide for the prevention of acute mountain sickness: time to move on.
    Penninga L; Wetterslev J; Penninga EI; Gluud C
    High Alt Med Biol; 2013 Mar; 14(1):85-6. PubMed ID: 23537267
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetazolamide and prevention of acute mountain sickness.
    Prescrire Int; 2014 Nov; 23(154):273. PubMed ID: 25954800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story.
    Swenson ER; Teppema LJ
    J Appl Physiol (1985); 2007 Apr; 102(4):1305-7. PubMed ID: 17194729
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis for acute mountain sickness.
    Fisher JA
    Hosp Pract (1995); 1998 Mar; 33(3):23. PubMed ID: 9522828
    [No Abstract]   [Full Text] [Related]  

  • 16. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
    Lipman GS; Jurkiewicz C; Burnier A; Marvel J; Phillips C; Lowry C; Hawkins J; Navlyt A; Swenson ER
    Am J Med; 2020 Dec; 133(12):e706-e715. PubMed ID: 32479750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B; Gertsch JH; Holck PS; Johnson EW; Luks AM; Donham BP; Fleischman RJ; Gowder DW; Hawksworth JS; Jensen BT; Kleiman RJ; Loveridge AH; Lundeen EB; Newman SL; Noboa JA; Miegs DP; O'Beirne KA; Philpot KB; Schultz MN; Valente MC; Wiebers MR; Swenson ER
    High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis for acute mountain sickness.
    Zafren K
    Ann Emerg Med; 2012 Nov; 60(5):671; author reply 672. PubMed ID: 23089097
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).
    McIntosh SE; Hemphill M; McDevitt MC; Gurung TY; Ghale M; Knott JR; Thapa GB; Basnyat B; Dow J; Weber DC; K Grissom C
    Wilderness Environ Med; 2019 Mar; 30(1):12-21. PubMed ID: 30630671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
    High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.